" The Dave Analyst: Allen initiated coverage with an Overweight rating and a price target of $480. The Dave Thesis: Founded in 2015, the company aims to solve the core problem of a timing gap between when salaries are paid and when bills are due.
It is also the fastest-growing (at over 25%) and most profitable (with margins around mid-40%) among its core peers. Check out other analyst stock ratings.
"We see ample demand for its short-duration liquidity products to sustain momentum (validated by our proprietary 3,000 person survey)," Allen said in the initiation note. 9% in 2027.
4 million, higher than Visa Inc (NYSE:V) and Chime Financial Inc (NASDAQ:CHYM) relative to 2025 headcount. Despite its healthy growth and profitability, its stock trades at a discount on most forward multiples, Allen pointed out.
Positive Estimate Revisions Likely: "Dave has a history of consistently beating and raising guidance and we see multiple levers that should continue to drive estimates higher in the coming quarters," the analyst wrote. " Its flagship liquidity product ExtraCash drives 85% of direct revenue.
Removing legacy fee caps allows the company to lift approval limits and average transaction sizes, resulting in higher ARPU (average revenue per user). 59 at the time of publication on Tuesday.
